Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

Tratamiento farmacologico

533 ARTíCULOS , VIENDO DEL 31 AL 45

PUBMED

Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer's disease

Uddin MS, Rahman MA, Kabir MT, Behl T, Mathew B, Perveen A, Barreto GE, Bin-Jumah MN, Abdel-Daim MM, Ashraf GM.

IUBMB Life. 2020 Sep;72(9):1843-1855. doi: 10.1002/iub.2324. Epub 2020 May 30.

0

0

0

PUBMED

Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?

Tufano M, Pinna G.

Molecules. 2020 Feb 27;25(5):1062. doi: 10.3390/molecules25051062.

0

0

0

PUBMED

Elevated serum TC and LDL-C levels in Alzheimer's disease and mild cognitive impairment: A meta-analysis study

Liu Y, Zhong X, Shen J, Jiao L, Tong J, Zhao W, Du K, Gong S, Liu M, Wei M.

Brain Res. 2020 Jan 15;1727:146554. doi: 10.1016/j.brainres.2019.146554. Epub 2019 Nov 23.

0

0

0

PUBMED

Baseline Prevalence of Polypharmacy in Older Hypertensive Study Subjects with Elevated Dementia Risk: Findings from the Risk Reduction for Alzheimer's Disease Study (rrAD)

Vidoni ED, Kamat A, Gahan WP, Ourso V, Woodard K, Kerwin DR, Binder EF, Burns JM, Cullum M, Hynan LS, Vongpatanasin W, Zhu DC, Zhang R, Keller JN.

J Alzheimers Dis. 2020;77(1):175-182. doi: 10.3233/JAD-200122.

0

0

0

PUBMED

Hydroxychloroquine safety: A meta-analysis of randomized controlled trials

Eljaaly K, Alireza KH, Alshehri S, Al-Tawfiq JA.

Travel Med Infect Dis. 2020 Jul-Aug;36:101812. doi: 10.1016/j.tmaid.2020.101812. Epub 2020 Jul 6.

0

0

0

PUBMED

Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant

Gonçalves ECD, Baldasso GM, Bicca MA, Paes RS, Capasso R, Dutra RC.

Molecules. 2020 Mar 29;25(7):1567. doi: 10.3390/molecules25071567.

0

0

0

PUBMED

The Effects of Probiotics and Prebiotics on Mental Disorders: A Review on Depression, Anxiety, Alzheimer, and Autism Spectrum Disorders

Ansari F, Pourjafar H, Tabrizi A, Homayouni A.

Curr Pharm Biotechnol. 2020;21(7):555-565. doi: 10.2174/1389201021666200107113812.

0

0

0

PUBMED

Molecular Insight into the Therapeutic Promise of Targeting APOE4 for Alzheimer's Disease

Mamun AA, Uddin MS, Bin Bashar MF, Zaman S, Begum Y, Bulbul IJ, Islam MS, Sarwar MS, Mathew B, Amran MS, Md Ashraf G, Bin-Jumah MN, Mousa SA, Abdel-Daim MM.

Oxid Med Cell Longev. 2020 May 15;2020:5086250. doi: 10.1155/2020/5086250. eCollection 2020.

0

0

0

PUBMED

Mitochondrial Calcium Signaling as a Therapeutic Target for Alzheimer's Disease

Wu AJ, Tong BC, Huang AS, Li M, Cheung KH.

Curr Alzheimer Res. 2020;17(4):329-343. doi: 10.2174/1567205016666191210091302.

0

0

0

PUBMED

Improvement of neuronal integrity with methylphenidate treatment for apathy in Alzheimer's disease

Padala PR, Padala KP, Samant RS, James GA.

Int Psychogeriatr. 2020 Apr;32(4):539-540. doi: 10.1017/S1041610220000095. Epub 2020 Feb 5.

0

0

0

PUBMED

Policy to Reduce Antipsychotic Use and Hospitalization of Nursing Home Residents With Dementia

Wang S, Temkin-Greener H, Conwell Y, Cai S.

J Am Med Dir Assoc. 2020 Nov;21(11):1617-1622.e3. doi: 10.1016/j.jamda.2020.04.005. Epub 2020 Jun 9.

0

0

0

PUBMED

Alzheimer's Disease and Functional Foods: An Insight on Neuroprotective Effect of its Combination

Hasnieza Mohd Rosli N, Mastura Yahya H, Shahar S, Wahida Ibrahim F, Fadilah Rajab N.

Pak J Biol Sci. 2020 Jan;23(5):575-589. doi: 10.3923/pjbs.2020.575.589.

0

0

0

PUBMED

Pesticides, cognitive functions and dementia: A review

Aloizou AM, Siokas V, Vogiatzi C, Peristeri E, Docea AO, Petrakis D, Provatas A, Folia V, Chalkia C, Vinceti M, Wilks M, Izotov BN, Tsatsakis A, Bogdanos DP, Dardiotis E.

Toxicol Lett. 2020 Jun 15;326:31-51. doi: 10.1016/j.toxlet.2020.03.005. Epub 2020 Mar 4.

0

0

0

PUBMED

Invited Review - Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials

Boche D, Nicoll JAR.

Neuropathol Appl Neurobiol. 2020 Dec;46(7):623-640. doi: 10.1111/nan.12642. Epub 2020 Jul 25.

0

0

0

PUBMED

Glycogen synthase kinase-3 signaling in Alzheimer's disease

Lauretti E, Dincer O, Praticò D.

Biochim Biophys Acta Mol Cell Res. 2020 May;1867(5):118664. doi: 10.1016/j.bbamcr.2020.118664. Epub 2020 Jan 30.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy